| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | |
| Div Cover | n/a | |
| Op Mrgn | 29.4% | |
| ROCE | 33.6% |
| Latest | F'cast | |
|---|---|---|
| P/E | 14.9 | |
| PEG | 0.0 | |
| Pr/Revenue | 3.8 | |
| Pr/Book | 3.8 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 21.2% | |
| PBT | 425.7% | |
| EPS | 4018.8% | |
| DPS | n/a |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | 2,986.27 | 570.44 | 430.00¢ | 17.1 | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 3,394.64 | 529.12 | 153.00¢ | 52.5 | n/a | -64% | n/a | 0.0% |
| 31-Dec-23 | 3,695.65 | 834.22 | 267.00¢ | 23.5 | 0.3 | +74% | n/a | 0.0% |
| 31-Dec-24 | 4,241.22 | 316.63 | 16.00¢ | 431.7 | n/a | -94% | n/a | 0.0% |
| 31-Dec-25 | 5,141.24 | 1,664.45 | 659.00¢ | 15.0 | 0.0 | +4,019% | n/a | 0.0% |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | 5,593.64 | 1,886.45 | 751.19¢ | 13.2 | 0.3 | +52% | n/a | 0.0% |
| 31-Dec-27 | 6,174.17 | 2,359.09 | 879.45¢ | 11.2 | 0.7 | +17% | n/a | 0.0% |
| 31-Dec-28 | 6,382.15 | 2,603.86 | 946.96¢ | 10.4 | 1.4 | +8% | n/a | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| FDA grants EUA for Eli Lilly treatment in conjun... | 20-Nov-2020 | ShareCast |
| Currency | US Dollars |
| Share Price | $ 97.10 |
| Change Today | $ -1.76 |
| % Change | -1.78 % |
| 52 Week High | $110.57 |
| 52 Week Low | $55.11 |
| Volume | 283,352 |
| Shares Issued | 198.46m |
| Market Cap | $19,270m |
| Beta | 0.05 |
| RiskGrade | 196 |
| Strong Buy | 7 |
| Buy | 5 |
| Neutral | 10 |
| Sell | 2 |
| Strong Sell | 0 |
| Total | 24 |

| Time | Volume / Share Price |
| 11:34 | 100 @ $97.10 |
| 11:34 | 249 @ $97.11 |
| 11:34 | 100 @ $97.17 |
| 11:34 | 100 @ $97.18 |
| 11:34 | 100 @ $97.17 |
You are here: research